Drug repurposing by integrated literature mining and drug-gene-disease triangulation.
暂无分享,去创建一个
Peng Sun | Jan Baumbach | Jiong Guo | Rainer Winnenburg | Jiong Guo | J. Baumbach | P. Sun | R. Winnenburg
[1] R. Sharan,et al. PREDICT: a method for inferring novel drug indications with application to personalized medicine , 2011, Molecular systems biology.
[2] Pankaj Agarwal,et al. Systematic Drug Repositioning Based on Clinical Side-Effects , 2011, PloS one.
[3] Hao Ye,et al. Construction of Drug Network Based on Side Effects and Its Application for Drug Repositioning , 2014, PloS one.
[4] Joel Dudley,et al. Exploiting drug-disease relationships for computational drug repositioning , 2011, Briefings Bioinform..
[5] Peer Bork,et al. The SIDER database of drugs and side effects , 2015, Nucleic Acids Res..
[6] O D Saugstad,et al. [D-penicillamine: old drug, new indication? D-penicillamine reduced pulmonary hypertension induced by free radicals]. , 1992, Orvosi hetilap.
[7] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[8] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[9] P. Pandolfi,et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. , 1998, The New England journal of medicine.
[10] Yongcui Wang,et al. Drug Repositioning by Kernel-Based Integration of Molecular Structure, Molecular Activity, and Phenotype Data , 2013, PloS one.
[11] Vijay S. Pande,et al. SWEETLEAD: an In Silico Database of Approved Drugs, Regulated Chemicals, and Herbal Isolates for Computer-Aided Drug Discovery , 2013, PloS one.
[12] Ying Zhang,et al. New drug candidates and therapeutic targets for tuberculosis therapy. , 2006, Drug discovery today.
[13] Sander R. Dubovy,et al. SHORT-TERM SAFETY AND EFFICACY OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2006, Retina.
[14] Xia Jing,et al. Targeted Inhibition of Src Kinase with Dasatinib Blocks Thyroid Cancer Growth and Metastasis , 2012, Clinical Cancer Research.
[15] M. Schroeder,et al. Drug repositioning through incomplete bi-cliques in an integrated drug-target-disease network. , 2012, Integrative biology : quantitative biosciences from nano to macro.
[16] N. Simon,et al. Ropinirole for antidepressant-induced sexual dysfunction , 2002, International clinical psychopharmacology.
[17] Min-Seok Kwon,et al. IDMap: facilitating the detection of potential leads with therapeutic targets , 2008, Bioinform..
[18] S. Hebbring. The challenges, advantages and future of phenome-wide association studies , 2014, Immunology.
[19] M. Wong,et al. In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug , 2015, PloS one.
[20] Philip E. Bourne,et al. PROMISCUOUS: a database for network-based drug-repositioning , 2010, Nucleic Acids Res..
[21] A. J. Crowle,et al. Chlorpromazine: a drug potentially useful for treating mycobacterial infections. , 1992, Chemotherapy.
[22] Joseph Mullen,et al. Mining integrated semantic networks for drug repositioning opportunities , 2016, PeerJ.
[23] Xin Wu,et al. Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity. , 2014, Molecular bioSystems.
[24] Alexander A. Morgan,et al. Supplementary Materials for Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease , 2011 .
[25] Raed A Dweik,et al. Alterations of cellular bioenergetics in pulmonary artery endothelial cells , 2007, Proceedings of the National Academy of Sciences.
[26] Thomas C. Wiegers,et al. The Comparative Toxicogenomics Database's 10th year anniversary: update 2015 , 2014, Nucleic Acids Res..
[27] Robert M. Plenge,et al. Disciplined approach to drug discovery and early development , 2016, Science Translational Medicine.
[28] François Schiettecatte,et al. OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders , 2014, Nucleic Acids Res..
[29] W. Ondo,et al. Ropinirole for restless legs syndrome , 1999, Movement disorders : official journal of the Movement Disorder Society.
[30] Miguel Viveiros,et al. Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps. , 2007, The Journal of antimicrobial chemotherapy.
[31] Egon L. Willighagen,et al. The Chemistry Development Kit (CDK): An Open-Source Java Library for Chemo-and Bioinformatics , 2003, J. Chem. Inf. Comput. Sci..
[32] R. Tagliaferri,et al. Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.
[33] Alexander A. Morgan,et al. Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease , 2011, Science Translational Medicine.
[34] David S. Wishart,et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..
[35] Simon M Lin,et al. Opportunities for drug repositioning from phenome-wide association studies , 2015, Nature Biotechnology.
[36] H P Koeffler,et al. Effect of dasatinib against thyroid cancer cell lines in vitro and a xenograft model in vivo. , 2012, Oncology letters.
[37] Asher Mullard,et al. 2015 FDA drug approvals , 2016, Nature Reviews Drug Discovery.
[38] Fu Lm,et al. Thalidomide and tuberculosis. , 2002 .
[39] Sanjay Joshua Swamidass,et al. Mining small-molecule screens to repurpose drugs , 2011, Briefings Bioinform..
[40] C E Lipscomb,et al. Medical Subject Headings (MeSH). , 2000, Bulletin of the Medical Library Association.
[41] A. Chiang,et al. Systematic Evaluation of Drug–Disease Relationships to Identify Leads for Novel Drug Uses , 2009, Clinical pharmacology and therapeutics.